Scientists from Australia & UK have created a “biosensor mouse” that predicts spread of pancreatic cancer cells https://t.co/SxgnGBSh7O
— GNN Good News (@GNNGoodNews) January 6, 2016If dying Steve Jobs
And Andrew Lloyd Webber
Wrote a Musicome
"Aren't you tired of all those
It would tell the story
Of that cool genome
Who is this Jesus CRISPr?
With a sick son
Get a Nobel Prize.
"Cracking the Code"
"Fixing the Code"
All done by parents:
The Mission Massimo team.
Nobody else seems
to be in charge.
Not even doctors
Not even scientists
Not even academia
Not even big pharma.
Mission Massimo was crazy.
But at M.I.T.
I was told that
"Crazy" could earn you a Nobel Prize
Even if you have no PhD
But end up
Jesus CRISPr and Mission Massimo
Did some disease modeling on a mouse
Then they built a platform
To cure thousands of people.
Three decades later
Old Mission Massimo
Steals the show.
Jesus CRISPr Superstar
Sharing a Nobel Prize
With the crazy people.
A big day for genome editing & hope in muscular dystrophy: #CRISPR corrects in mouse model https://t.co/9B8d5kXzbe pic.twitter.com/DaTB0QS7r6— Eric Topol (@EricTopol) December 31, 2015
Just wrote my review of #CrackingTheCode in German on @Amazon https://t.co/WrJ9OwsXbz cc @missionmassimo @leahkam pic.twitter.com/YyHS6EpUEa— CATHERINE COSTE (@cathcoste) January 2, 2016
Jesus #CRISPR Superstar, a remake of Lloyd Webber #musical, w/ @MIT stars @eric_lander @zhangf. Superstar: bacteria. https://t.co/03fumRxh77— CATHERINE COSTE (@cathcoste) January 21, 2016
Controversial CRISPR history sets off an online firestorm! More interesting than Amy awards or RealityTV storms... https://t.co/1JdZlxFk5U— Guillaume Plane (@GuillaumePlane) January 20, 2016
Hoping that #CRISPR patent battle will not be a remake of the War of Currents with Thomas Edison VS Nikola Tesla - https://t.co/aWhlx0wufh— CATHERINE COSTE (@cathcoste) January 23, 2016
.@EricTopol Hoping that #CRISPR legal war won't be a remake of the War of Currents with Thomas Edison VS Nikola Tesla #lawyerswillgetricher— CATHERINE COSTE (@cathcoste) January 24, 2016
This biotech company is trying to make a rare disease drug cheaper. Will it work? https://t.co/O3ufrf6bwn pic.twitter.com/ZKAZcAuZVs— STAT (@statnews) 24 Janvier 2016
Interesting CRISPR history https://t.co/HsVJrFd6Ud The seminal observations were rejected in every high-IF journal! pic.twitter.com/cnmT9zXAhT— Victor de Lorenzo (@vdlorenzo_CNB) January 15, 2016
.@KellyLaMarco @broadinstitute Also a rare form of patient activism #raredisease https://t.co/8dA1D96vrI @leahkam pic.twitter.com/yXEHAXusKo— CATHERINE COSTE (@cathcoste) January 25, 2016
The videos from this course are useful for a #scifi writer :-) #Programing #EricGrimson #Python #MIT #6001x @cp92isa https://t.co/1ogwoQcMJ0— CATHERINE COSTE (@cathcoste) January 25, 2016
Intro to Computer Science & #Programming starts today! Learn a new skill in the new year: https://t.co/Lk5X0UIHwA pic.twitter.com/1MaQc40fzb— MITx on edX (@MITxonedX) January 13, 2016
Creating #biologic #medicines is a complex process comprised of four main steps. https://t.co/RQpLWxE4Rw— Amgen Biosimilars (@AmgenBiosim) January 19, 2016
Lander's message to Broad Institute regarding "Heroes of Crispr" conflagration. pic.twitter.com/wPe99QhIri— Antonio Regalado (@antonioregalado) January 29, 2016